Walia et al. reported that PTPRD acts as a tumor-suppressor and was one of the most frequently mutated genes in cutaneous metastatic melanoma, mutant PTPRD loses the function of inhibiting cell proliferation and migration, some kind of mutants even promote cell migration (Walia et al., 2014). The gene discussed is PTPRD; the disease is metastatic melanoma.